Skip to main content
Clinical Trials/JPRN-UMIN000038109
JPRN-UMIN000038109
Completed
未知

Examination of impact on prognosis and recurrence Direct-Acting Antiviral for hepatitis C-related hepatocellular carcinoma after Treatment. - Examination of impact on prognosis and recurrence DAA for hepatitis C-related hepatocellular carcinoma after Treatment.

Matsuyama Red Cross Hospital0 sites300 target enrollmentSeptember 26, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Matsuyama Red Cross Hospital
Enrollment
300
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2019
End Date
March 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who have been refused participation in this study. 2\) Child\-Pugh before liver resection or RFA is B or C. 3\) Cases with distant metastasis before HCC treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials